1. Home
  2. AEVA vs CRVS Comparison

AEVA vs CRVS Comparison

Compare AEVA & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AEVA

Aeva Technologies Inc.

HOLD

Current Price

$15.42

Market Cap

1.0B

ML Signal

HOLD

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$15.94

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AEVA
CRVS
Founded
2019
2014
Country
United States
United States
Employees
239
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.2B
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
AEVA
CRVS
Price
$15.42
$15.94
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
6
Target Price
$26.50
$30.17
AVG Volume (30 Days)
1.5M
1.2M
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
48.04
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$85.37
N/A
Revenue Next Year
$132.72
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.83
$3.38
52 Week High
$38.79
$26.95

Technical Indicators

Market Signals
Indicator
AEVA
CRVS
Relative Strength Index (RSI) 52.41 52.31
Support Level $14.73 $13.81
Resistance Level $17.72 $19.21
Average True Range (ATR) 1.65 1.17
MACD -0.17 -0.03
Stochastic Oscillator 60.08 31.84

Price Performance

Historical Comparison
AEVA
CRVS

About AEVA Aeva Technologies Inc.

Aeva Technologies Inc through its Frequency Modulated Continuous Wave (FMCW) sensing technology, designs a 4D LiDAR-on-chip that, along with its proprietary software applications, has the potential to enable the adoption of LiDAR across broad applications from automated driving to consumer electronics, consumer health, industrial automation, and security application. The 4D LiDAR sensors are designed to detect both velocity and position, supporting perception and decision-making in automated systems. The company operates in North America, EMEA, and Asia. The company's revenue consists of sales of perception solutions or sensing systems and non-recurring engineering services. Geographically, it derives the majority of its revenue from North America.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.

Share on Social Networks: